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Abstract: This study aimed to evaluate clinical signs related with canine leishmaniosis (CanL) and to determine their relation with
serological results in the differential diagnosis of this disease in dog populations.
A total of 253 dogs from houses and a dog shelter in Kufladas›, an endemic region for leishmaniosis, were investigated for clinical
signs related to CanL. Sera collected from the study group were examined by indirect fluorescence antibody (IFA), whole ELISA and
rK39 ELISA tests for the serological diagnosis. Popliteal lymph node aspiration materials were examined for the parasitological
diagnosis.
Clinical signs were separated into two groups as cutaneous and visceral signs and no clinical signs were observed in 51.7%
(131/253) of the dogs, while 48.3% (122/253) of the dogs had at least one sign. A total of 42 dogs [29 (23.7%) in the
symptomatic and 13 (9.9%) in the asymptomatic group] were diagnosed as CanL serologically and/or parasitologically. Two strains
were isolated and identified as Leishmania infantum MON-1. There was no correlation between IFAT titers and the number of the
clinical signs (P > 0.05; R square = 0.002). Weight loss was found to be the most common sign of CanL while epistaxis was the
least common but specific sign.
The seropositivity ratio of CanL is 16.6% (42/253) among dogs in the region and clinical signs were found to be helpful for
suspecting CanL but at least one serological and/or parasitological method should be performed for the accurate and differential
diagnosis in the dogs. Our findings also showed that the one-third of the dogs in an endemic area for CanL could be asymptomatic.
Key Words: Canine leishmaniosis, clinical signs, diagnosis, Turkey

Köpek Leishmaniosisi Tan›s›nda Klinik ve Serolojik Bulgular›n Karfl›laflt›r›lmas›
Özet: Bu çal›flmam›zda köpek leishmaniosisi ile iliflkili olan klinik belirtilerin de¤erlendirilmesi ve köpeklerdeki bu hastal›¤›n ay›r›c›
tan›s›nda serolojik yöntemlerden al›nan sonuçlarla iliflkisinin belirlenmesi amaçlanm›flt›r. Köpek leishmaniosisi aç›s›ndan endemik bir
bölge olan Kufladas›’nda evlerde ve köpek evinde bulunan çeflitli ›rklardan toplam 253 köpek, köpek leishmaniosisinin klinik belirtileri
aç›s›ndan incelenmifltir. ‹ndirekt Floresan Antikor Testi (IFAT), düz ELISA ve rK39-ELISA serolojik testler olarak uygulanm›fl ve
parazitolojik inceleme için popliteal lenf aspirasyonu yap›lm›flt›r.
Klinik belirtiler, visseral ve deri belirtileri olarak iki gruba ayr›lm›fl ve köpeklerin % 48,3’ünde (122/253) en az bir belirti saptan›rken
% 51,7’sinde (131/253) hiçbir belirti olmad›¤› görülmüfltür. Toplam 42 köpe¤e [semptomatik köpeklerin 29 (% 23,7)’una ve
asemptomatik köpeklerin 13 (% 9,9)’üne] serolojik ve/veya parazitolojik olarak köpek leishmaniosisi tan›s› konulmufltur. Aspirasyon
örneklerinden iki sufl izole edilmifl ve Leishmania infantum MON-1 olarak tan›mlanm›flt›r. IFA testinde pozitiflik saptanan suland›r›m›n
yüksekli¤i ile klinik belirtilerin say›s› aras›nda herhangi bir uygunluk saptanmam›flt›r (P > 0,05; R kare = 0,002). Kilo kayb› en
yayg›n, burun kanamas› ise en az görülen ama özgül olan semptom olarak bulunmufltur.
Köpek leishmanosisinin ülkemizin bat›s›nda yayg›n (% 16,6) ve klinik belirtilerin bu hastal›ktan flüphelenilmesinde yard›mc› oldu¤u
ancak kesin ve ay›r›c› tan› için mutlaka serolojik veya parazitolojik testlere gereksinim duyuldu¤u görülmüfltür. Ayr›ca, köpeklerin
1/3’ünün de seropozitif oldu¤u halde asemptomatik olabilece¤ine dikkat çekilmifltir.
Anahtar Sözcükler: Köpek leishmaniosisi, klinik bulgular, tan›, Türkiye
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Introduction
Visceral leishmaniosis (VL) caused by Leishmania
infantum is a human zoonotic infection throughout the
Mediterranean basin including Turkey. Dogs and rodents
are accepted as the most important reservoirs, and the
disease is transmitted by vector Phlebotomine sand flies
(1-3). Canine leishmaniosis (CanL) is a common disease
among dog populations in the Mediterranean area (3,4).
Diagnosis of leishmaniosis in humans and dogs is crucial
for controlling the disease and understanding its
epidemiology. Direct microscopic examination and in vitro
culture of tissue aspirates are still considered as the "gold
standard" in the diagnosis, although it is a time
consuming and invasive method (3). In the last decade,
several serological tests with comparable rates of
reliability have been developed and widely used especially
in epidemiological surveys (5-8).
The clinical features of CanL vary widely. Skin lesions,
loss of weight or poor appetite, local or generalized
lymphadenopathy, ocular lesions, splenomegaly, fever,
dermatitis, epistaxis, melena are commonly identified on
physical examination of dogs. Cutaneous lesions
characterized by hyperkeratosis, scaling, thickening,
mucocutaneous ulcers and intradermal nodules on
muzzle, pinnae, ears and footpads are detected in
approximately 90% of the infected dogs (3,9).
CanL is very important as a fatal and non-curable
disease of canines. Also, the persistence of the disease
puts both healthy dogs and humans at risk in endemic
sites. There have only been limited studies on CanL
throughout Turkey. Seroprevalence of CanL was
previously found to be between 3.6-19% in the villages
of the Manisa city. Specific symptoms of CanL, such as
enlargement of popliteal lymph nodes, skin lesions,
depilation, weight loss and/or spontaneous death were
observed in a limited number of seropositive dogs (8). In
a study carried out in Kufladas›, 109 dogs kept at the dog
shelter belonging to the Kufladas› Municipality were
screened serologically using indirect fluorescence
antibody test (IFAT) and recombinant K39-ELISA and the
seropositivity ratio was found to be as 9.1% (10).
Although clinical features may be indicative and
helpful for the diagnosis of the disease in dogs, due to the
natural genetic heterogeneity of the canine population,
these signs mimic those of other diseases (1,4).
Serological diagnosis is considered to be essential for
evaluating the prevalence of Leishmania infections
especially among asymptomatic dogs (3).
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This study aimed to evaluate the clinical signs related
with CanL and to determine their relation with the
serological results in the differential diagnosis of the
disease.
Materials and Methods
Kufladas› was chosen as study area because of it is an
important endemic region for canine leishmaniosis and
has an importance as a tourist town of Turkey.
Clinical signs were evaluated in 253 dogs from
Kufladas› / Ayd›n between the dates 1997 and 2001 and
separated into two groups as visceral (fever, weight loss,
fatigue, lymphadenopathy, conjunctivitis, epistaxis) and
cutaneous
(depilation,
scaling,
skin
ulcer,
onychogryphosis) signs (11).
The dogs showing these signs came from two
different sources; (i) the dogs (Kangal, boxer, German
shepherd, Doberman, terrier, Dalmatian, mix, etc.)
serving as pets and guards in the residential houses and
farms in urban area of Kufladas› and (ii) dogs living in the
dog shelter belonging to Kufladas› municipality, located in
the town. The dogs kept in the shelter were mix bred and
came from urban and rural areas of Kufladas›.
Five ml venous blood samples were collected from
each dog by brachial vein puncture for serological tests.
Serological Tests:
The antigen was prepared using promastigotes from
local Leishmania infantum MON-1 strain obtained by mass
culturing in RPMI-1640 containing 10% FCS.
Indirect fluorescence antibody test (IFAT) was
performed using standard procedures and two-fold serial
dilution from 1:16 to 1:16.384 of dog sera in PBS was
used. Titers of ≥1:128 were considered as positive for
CanL and the titer of 1:64 was accepted as the borderline
titer according to preliminary studies (6).
ELISA; was performed as described before, using
1:100 single serum dilution, rabbit anti-dog IgG
conjugated with horseradish peroxidase (Sigma) at
1:1000 dilution and a 2, 2’-azino-bis (3-ethylbenzthiozoline-6-sulfonic acid) (ABTS) substrate. The optical
density was measured at 405 nm. Cut-off value was
determined as the mean of the absorbance of two
negative controls plus three standard deviations (12).
Recombinant K39 Enzyme Linked Immunosorbent
Assay (rK39-ELISA); was performed as explained in
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whole ELISA, except the purified rK39 antigen at a
concentration of 20 ng per well (8).
Parasitological examination
A total of 66 popliteal lymph node aspirations were
applied using 21G needles and examined under the
microscope (x1000) after staining with Giemsa, and
inoculated into NNN culture for isolating the parasite.
Parasitological examination was accepted as positive with
smear and/or culture positivity.
Statistical analysis
The correlation between IFAT titers and the number
of the clinical signs were evaluated by regression analysis
in SPSS for Windows.

borderline) dogs and 32 (31 from seropositive and 1
from borderline) aspiration samples were found to be
positive with smear and/or culture examinations. Two
strains were isolated and identified as Leishmania
infantum MON-1 by isoenzyme analysis in Montpellier,
France.
The percentage of clinical signs among 42 seropositive
dogs was given in Table 2. Weight loss was found to be
the most common sign of CanL while epistaxis was the
least common sign. Conjunctivitis, epistaxis and
onychogryphosis were found to be most specific signs of
CanL.
Table 2. Clinical signs percentages among 42 seropositive dogs.
Clinical signs

Results

Cutaneous signs

One or more visceral and/or cutaneous clinical signs
were recorded in 48.3% (122/253) while no sign was
observed in 51.7% (131/253) of the dogs.
A total of 42 dogs out of 253 were diagnosed as CanL
serologically and/or parasitologically. Ninety-seven
percent concordance between three tests was found and
there was no correlation between IFAT titers and the
number of the clinical signs (P > 0.05; R square =
0.002). The comparative results of the dogs according to
clinical signs and the serological results are summarized in
Table 1.
The 29 dogs confirmed with CanL were also grouped
according to signs as follows: two dogs (6.9%) showed
only one or two signs, 20 dogs (69%) showed three to
five signs and seven dogs (24.1%) showed six to nine
signs.
Popliteal lymph node aspirations were applied to 66
(34 from seropositive, 26 from seronegative and 6 from

Visceral signs

Skin ulcer
Onychogryphosis
Depilation
Scaling
Weight loss
Fever
LAP
Fatigue
Conjunctivitis
Epistaxis

No sign

n

%

16
15
15
13
21
16
14
13
10
5

38
35.7
35.7
30.9
50
38
33.3
30.9
23.8
11.9

13

30.9

Discussion
The results obtained from the present work on the
clinical signs of CanL gathered new data for
understanding of the epidemiology of this infection in
Turkey. In the present study, 30.9% (13/42) of the
seropositive dogs showed none of the signs of CanL. This
result indicates that epidemiological studies that only take
symptomatic dogs into account should under-estimate the

Table 1. The relationships between group of signs and serological results in 253 clinically investigated dogs.
Serological Results
Clinical Signs

Seronegative
n (%)

Borderline
n (%)

Visceral sign(s)

69 (94.5)

1 (1.3)

3 (4.1)

73

Cutaneous sign(s)

11 (91.7)

0

1 (8.3)

12

Visceral and cutaneous signs

11 (29.7)

1 (2.7)

25 (67.6)

37

No sign

109 (83.2)

9 (6.8)

13 (9.9)

131

200

11

42

253

Total

Seropositive
n (%)

Total
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prevalence of infection in dogs by about one-third. This is
in agreement with other studies, which concluded that a
high proportion of infected dogs are asymptomatic.
Therefore, serodiagnosis is absolutely essential in
evaluating the prevalence of CanL in large dog
populations (1,13,14) and in the diagnosis of individual
cases (15).
Three commonly used serological tests were
performed in the study because of reliable comparison
with clinical signs and all three tests showed a 97%
concordance and discriminated the positives equally. In
previous studies performed in human VL endemic sites in
Turkey, the CanL seropositivity rate was ranged from 3.6
to 19% in randomly selected dog populations (8). CanL
seropositivity rate was found to be 9.1% among
randomly selected dogs in the dog shelter of Kufladas›
(10). However, the CanL rate for Kufladas› in this study
was 23.7% (29/122) among dogs having clinical signs.
Therefore, dogs with clinical signs found to have a
positivity rate that is almost three times greater than a
randomly selected population. These results indicated
that the dogs having one or more of these clinical signs
should be suspected for CanL as reported in a case (15)
in Turkey. For an accurate diagnosis, serological
examinations are more valuable, rapid and less invasive
than parasitological procedures. Although epistaxis and
conjunctivitis were found to be rare signs, they were
found to be more specific than other common signs of
CanL cases.
In the present study, 69% (29/42) of the seropositive
group showed signs of CanL. In other studies, skin
involvement was reported to be between 81 to 100%
(4,16), while it was found to be 61.9% (26/42) and
visceral involvement was seen in 67% (28/42) of the
seropositive dogs in our study. One and 3 dogs were
showed only cutaneous and visceral signs respectively
while the majority group of seropositive dogs were
showed visceral and cutaneous signs together (59.5%,
25/42) similar to an earlier report (11).
There was no correlation between the IFAT titers and
the number of clinical signs (P > 0.05; R square =

0.002). This is also in concordance with earlier reports
(2,6) and one of most valuable finding in the study in
order to show importance of serological methods. The
percentage of clinical signs of the dogs included our study
are in concordance with the previously related literature
(4,16).
Popliteal lymph node aspirations were done on 66
among 253 dogs to verify the reliability of the serological
tests. None of the seronegative dogs and 31 out of 34
(91.1%) seropositive dogs were found to be positive by
parasitological examination. Failure to detect parasites by
parasitological examination in three out of 34
seropositive dogs and also in five out of six borderline
dogs may be due to either very low parasite levels or the
dog may have gone through a subclinical infection in the
past. There is a need to control borderline dogs with
regular intervals.
In the present study, euthanasia was performed to 19
out of 42 seropositive dogs by an authorized veterinary
surgeon following the permission of their owners while
nine of them died spontaneously. Drug therapy with
antimonials is in trial in the remaining 14 positive dogs
with the help of their owners. They are also using
insecticide-impregnated dog collars in order to protect
the dogs from sand fly bites and prevent the disease from
spreading to other dogs and possibly to humans.
In conclusion, our results demonstrate that CanL is
widespread among dogs in western Turkey and the
number of the clinical signs is very helpful for suspecting
CanL but at least one serological and/or parasitological
method should be performed for certain and differential
diagnosis of the disease in the dogs. However, our
findings showed that the one-third of the dogs in an
endemic area of CanL could be asymptomatic.
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